CVS Caremark CEO Merlo's 2011 Pay Jumped 29% To $14.1 Million
March 15 2012 - 5:50PM
Dow Jones News
Total pay for CVS Caremark Corp.'s (CVS) chief executive and
president, Larry J. Merlo, grew 29% to $14.1 million last year,
according to a filing with the Securities and Exchange
Commission.
The drugstore retailer and pharmacy-benefits manager disclosed
that Merlo's base salary, option awards and nonequity
incentive-plan compensation all increased, while stock awards were
lower.
Merlo first joined the company in 1998 and has served in several
executive roles, including chief operating officer and president of
CVS/pharmacy. He took on his current roles a year ago.
Chief Financial Officer Dave Denton's total pay jumped 35% to
$4.6 million. Denton has been with CVS since 1999.
Per Lofberg, president of CVS Caremark Pharmacy Services, saw
his pay decline 55% to $7.1 million, as he joined CVS at the
beginning of 2010 and was thus awarded a $1.5 million bonus and $7
million in stock awards during the prior-year period.
President of CVS/pharmacy, Mark Cosby, joined CVS last September
and was compensated $9.6 million last year. That figure includes a
nearly $1.4 million bonus and over $7 million in stock and option
awards.
CVS's shares ended last year with a 17% gain, exceeding the
broader market's growth as investors and analysts praised the
company's integration of pharmacy-benefits manager Caremark. CVS
has touted the success of its MinuteClinic retail health-care
centers, and observers are banking on the retailer to benefit from
the contract expiration between rival Walgreen Co. (WAG) and PBM
Express Scripts Inc. (ESRX).
CVS shares closed down 0.5% to $44.88 and were flat after hours.
The stock is up 10% this year.
-By John Kell, Dow Jones Newswires; 212-416-2480;
john.kell@dowjones.com
CVS Health (NYSE:CVS)
Historical Stock Chart
From Jun 2024 to Jul 2024
CVS Health (NYSE:CVS)
Historical Stock Chart
From Jul 2023 to Jul 2024